Table 1.
Medical benefits and pharmacologic properties of the major constituents in Acacia confusa.
Pharmacologic properties | Major constituentsa | References |
---|---|---|
Antioxidant and radical scavenging activities | 11, 28, 32, 47 | 10, 12, 13, 22 |
Hepatoprotective effects | 11 | 32 |
Xanthine oxidase inhibitory activity | 26, 28, 32, 36 | 9, 14, 41 |
Semicarbazide-sensitive amine oxidase inhibitory activity | 47, 48, 49, 50, 51 | 47 |
Angiotensin I converting enzyme inhibitory activity | 49, 50, 51 | 47 |
Antihyperuricemic effect | 18, 21, 28, 29, 32 | 9 |
Anti-inflammatory activity | 28 | 7 |
Anti-hepatitis C virus activity | Ceramides | 57 |
Immunoregulatory activity | 28, 47b | 68, 73b |
Anti-osteoclastogenic effect | 25b, 26b | 74b, 75b |
Cancer cell cytotoxicity | 47, 48, 49, 50 | 23 |
Psychedelic effects | 53b | 79b , 80b , 81b , 82b , 83b , 84b , 85b , 86b |
The chemical structures of the major constituents are referred to Fig. 2.
Pharmacologic properties of the constituents were determined from other plant species or commercial suppliers.